» Articles » PMID: 27082824

Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates

Overview
Date 2016 Apr 16
PMID 27082824
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The objective of this study was to compare aerosol deposition predictions of a new whole-airway CFD model with available in vivo data for a dry powder inhaler (DPI) considered across multiple inhalation waveforms, which affect both the particle size distribution (PSD) and particle deposition.

Methods: The Novolizer DPI with a budesonide formulation was selected based on the availability of 2D gamma scintigraphy data in humans for three different well-defined inhalation waveforms. Initial in vitro cascade impaction experiments were conducted at multiple constant (square-wave) particle sizing flow rates to characterize PSDs. The whole-airway CFD modeling approach implemented the experimentally determined PSDs at the point of aerosol formation in the inhaler. Complete characteristic airway geometries for an adult were evaluated through the lobar bronchi, followed by stochastic individual pathway (SIP) approximations through the tracheobronchial region and new acinar moving wall models of the alveolar region.

Results: It was determined that the PSD used for each inhalation waveform should be based on a constant particle sizing flow rate equal to the average of the inhalation waveform's peak inspiratory flow rate (PIFR) and mean flow rate [i.e., AVG(PIFR, Mean)]. Using this technique, agreement with the in vivo data was acceptable with <15% relative differences averaged across the three regions considered for all inhalation waveforms. Defining a peripheral to central deposition ratio (P/C) based on alveolar and tracheobronchial compartments, respectively, large flow-rate-dependent differences were observed, which were not evident in the original 2D in vivo data.

Conclusions: The agreement between the CFD predictions and in vivo data was dependent on accurate initial estimates of the PSD, emphasizing the need for a combination in vitro-in silico approach. Furthermore, use of the AVG(PIFR, Mean) value was identified as a potentially useful method for characterizing a DPI aerosol at a constant flow rate.

Citing Articles

Modeling aerosol bolus inhalations in the human lung with the Multiple Path Particle Deposition model: Comparison with experimental data.

Asgharian B, Price O, Borojeni A, Kuprat A, Colby S, Singh R J Aerosol Sci. 2025; 185.

PMID: 40060110 PMC: 11884729. DOI: 10.1016/j.jaerosci.2025.106547.


The effects of airway disease on the deposition of inhaled drugs.

Darquenne C, Corcoran T, Lavorini F, Sorano A, Usmani O Expert Opin Drug Deliv. 2024; 21(8):1175-1190.

PMID: 39136493 PMC: 11412782. DOI: 10.1080/17425247.2024.2392790.


Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels.

Jubaer H, Thomas M, Farkas D, Kolanjiyil A, Momin M, Hindle M J Aerosol Sci. 2024; 175:106262.

PMID: 38164243 PMC: 10698304. DOI: 10.1016/j.jaerosci.2023.106262.


Automated bidirectional coupling of multiscale models of aerosol dosimetry: validation with subject-specific deposition data.

Kuprat A, Price O, Asgharian B, Singh R, Colby S, Yugulis K J Aerosol Sci. 2023; 174.

PMID: 37637507 PMC: 10448711. DOI: 10.1016/j.jaerosci.2023.106233.


Mechanistic modeling of generic orally inhaled drug products: A workshop summary report.

Walenga R, Butler C, Craven B, Longest P, Mohamed R, Newman B CPT Pharmacometrics Syst Pharmacol. 2022; 12(5):560-574.

PMID: 36330693 PMC: 10196431. DOI: 10.1002/psp4.12889.


References
1.
Finlay W, Martin A . Recent advances in predictive understanding of respiratory tract deposition. J Aerosol Med Pulm Drug Deliv. 2008; 21(2):189-206. DOI: 10.1089/jamp.2007.0645. View

2.
Cheng K, Cheng Y, Yeh H, Swift D . Measurements of airway dimensions and calculation of mass transfer characteristics of the human oral passage. J Biomech Eng. 1998; 119(4):476-82. DOI: 10.1115/1.2798296. View

3.
Longest P, Son Y, Holbrook L, Hindle M . Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols. Pharm Res. 2013; 30(6):1608-27. PMC: 3703624. DOI: 10.1007/s11095-013-1001-z. View

4.
Wongviriyawong C, Harris R, Greenblatt E, Winkler T, Venegas J . Peripheral resistance: a link between global airflow obstruction and regional ventilation distribution. J Appl Physiol (1985). 2012; 114(4):504-14. PMC: 3569839. DOI: 10.1152/japplphysiol.00273.2012. View

5.
Ma B, Lutchen K . CFD simulation of aerosol deposition in an anatomically based human large-medium airway model. Ann Biomed Eng. 2008; 37(2):271-85. DOI: 10.1007/s10439-008-9620-y. View